No abstract

Various tumors and tumor-like lesions of bone and cartilage were examined for S-100 protein using the avidine-biotin-peroxidase complex (ABC) immunostaining method. The most intense reactivity for S-100 protein was found in well-differentiated chondrocytes of enchondromas, osteochondromas and chondrosarcomas, and in normal epiphyseal cartilage. S-100 protein was positive in both polygonal stromal cells and chondrocytes of chondroblastomas and in chondrocytes of mesenchymal chondrosarcoma. In osteosarcomas not only chondroblastic areas but also osteoblastic areas showed positive cells. Reticulum histiocytic cells of eosinophilic granulomas and chordoma cells were positive for S-100 protein. The study yielded three main conclusions: (1) S-100 protein could be the marker for tumors of cartilaginous origin and differentiation, notochord origin, and T-zone histiocyte origin; (2) chondroblastoma can be distinguished from other histologically confusing giant cell lesions by using ABC to detect S-100 protein; and (3) S-100 protein has some relationship with tumoral calcification not only in cartilaginous tumors but also in osteosarcoma.

In 38 cases of Stage I lung cancer, for which surgery was not indicated because of poor cardiopulmonary function or other reason, radical irradiation yielded excellent results. The five year survival rate was 42.1%, the 10-year survival rate 28.4% and the 15-year survival rate 17.1%. Postradiation complications which can be life-threatening, were acceptably low in incidence, and there was no radiation-related death. The results support the concept of radical irradiation being acceptable as a treatment modality for Stage I lung cancer if the patients concerned cannot have surgery because of poor cardiopulmonary function or some other reason.

Acoustic pulse generationin excised muscle by pulsed proton beam irradiation and the possibility of clinical application to radiation therapy

A Its well-defined range of penetration and Brag peak enables it to provide concentrated irradiation to the tumor area, sparing normal tissues located deeper than the peak. In conventional radiation therapy (RT), brachytherapy has often played a role in achieving superior physical dose distribution. Proton beam RT has a much sharper distal fall-off than that of brachytherapy and is more flexible in shaping the treatment volume by modulating its range and peak width. More flexible applications to any site of the tumor, where brachytherapy is not easily accessible, is another advantage of proton beam RT. These potential advantages of proton beam RT are worth testing in clinical settings for certain tumors in which brachytherapy plays an essential part in treatment.